We are Sorry, This Page doesn't Exist
Blue Tower Asset Management 1Q20 Commentary: The paradox of value investing
Blue Tower Asset Management commentary for the first quarter ended March 31, 2020, discussing value stocks con.....»»
Blue Tower Asset Management Q2 2019 Commentary
Blue Tower Asset Management Q2 2019 Commentary.....»»
Blue Tower Asset Management 2Q19 Commentary: Long Construction Sector
Blue Tower Asset Management 2Q19 Commentary: Long Construction Sector.....»»
Blue Tower Asset Management 2Q18 Commentary Long Sberbank
Blue Tower Asset Management commentary for the second quarter ended June 30, 2018. Q2 hedge fund letters, conferenc.....»»
Blue Tower Asset Management Q2 "18 Commentary Long Sberbank
Blue Tower Asset Management Q2 "18 Commentary Long Sberbank.....»»
Blue Tower Asset Management 3Q18 Commentary: Enova
Blue Tower Asset Management commentary for the third quarter ended September 30, 2018; discussing their investment thesis in Enova.....»»
Blue Tower Asset Management Q3 2018 Commentary: Enova
Blue Tower Asset Management Q3 2018 Commentary: Enova.....»»
Blue Tower Asset Management 4Q18 Commentary: Long Joban Kaihatsu
Blue Tower Asset Management commentary for the fourth quarter ended December 31, 2018, providing an update on Joban Kaihatsu. The Global Value strategy composite returned -17.10% gross (-17.34% net) for Q4. D.....»»
Baron Funds on ICON Public Ltd Co. (ICLR): “We See Significant Upside in the Stock Price”
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2021 investor letter – a copy of which can be.....»»
Is BridgeBio Pharma Inc. (BBIO) A Smart Long-Term Buy?
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2021 investor letter – a copy of which can be.....»»
Should You Retain Your Arrowhead Pharmaceuticals (ARWR) Position?
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2021 investor letter – a copy of which can be.....»»
Here’s Why Baron Health Care Fund Sold its Biohaven Pharmaceutical (BHVN) Position
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2021 investor letter – a copy of which can be.....»»
Is Denali Therapeutics Inc. (DNLI) A Smart Long-Term Buy?
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2021 investor letter – a copy of which can be.....»»
Baron Health Care Fund: “Beam Therapeutics (BEAM) has a Unique Platform Technology”
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2021 investor letter – a copy of which can be.....»»
Stewart Asset Management is Bullish on Match Group (MTCH), Here’s Why
Stewart Asset Management, an investment management firm, published its first quarter 2021 investor letter – a copy of which can be seen .....»»
Here’s Why Stewart Asset Managment Sold its Apple (AAPL) Shares
Stewart Asset Management, an investment management firm, published its first quarter 2021 investor letter – a copy of which can be seen .....»»
Brookfield Asset Management (BAM): Strong Growth And Abundant Potential
Alphyn Capital recently released its Q1 2020 Investor Letter, a copy of which you can download below. The fund posted a return of -21.7% for .....»»
Hedge Fund and Insider Trading News: Dan Loeb, Paul Tudor Jones, Warren Buffett, Reminiscent Capital, Brevan Howard Asset Management, World Wrestling Entertainment, Inc. (WWE), Raymond James Financial, Inc. (RJF), and More
Dan Loeb’s Far Point Urges Investors to Scrap Global Blue Buyout (Reuters) (Reuters) – Blank-check company Far Point Acquisition.....»»
Francisco Garcia Parames" Cobas Asset Management 1st-Quarter Letter
Discussion of markets and holdingsCheck out Francisco Garcia Parames Stock Picks » Download GuruFolio Report of Francisco Garcia Parames (Updated on 04/30/2020)Related Stocks: TGP, LSE:BAB, MIL:CIR,.....»»
Massif Capital is Bullish on Star Bulk (SBLK), Bearish on John Deere (DE)
North Carolina-based asset management firm Massif Capital, LLC released its first-quarter investor letter this month – a copy of which is av.....»»